Overview

Citicoline as Neuroprotector in Preterm

Status:
Recruiting
Trial end date:
2028-12-01
Target enrollment:
Participant gender:
Summary
Citicoline as neuroprotector in preterm
Phase:
Phase 3
Details
Lead Sponsor:
Sherief Abd-Elsalam
Treatments:
Cytidine Diphosphate Choline